Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure

Journal of Critical Care

Volumn 16, Issue 2, 2001, Pages 59-63

  Nakae, Hajime ^a,b   Narita, Kyoko ^a,b   Endo, Shigeatsu ^a,b  

^a AKITA UNIVERSITY   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; LIGAND; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMEOSTASIS; HUMAN; INTENSIVE CARE; LIVER FAILURE; LIVER PROTECTION; MALE; SEPSIS;

EID: 0034899836     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcrc.2001.25470     Document Type: Article

References (32)

1. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
2. Lethal effect of the anti-Fas antibody in mice
3. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
4. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
5. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
6. Expression of the Fas ligand in cells of T cell lineage
7. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models
8. Fas-mediated apoptosis in primary cultured mouse hepatocytes
9. Apoptosis in cultured rat hepatocytes: The effects of tumour necrosis factor alpha and interferon gamma
10. Continuous removal of middle molecules by hemofiltration in patients with acute liver failure
11. Circulating proinflammatory cytokines (IL-Iβ, TNF-α, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis
12. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
13. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
14. Apoptosis by death factor
15. The Fas death factor
16. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
17. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
18. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metallo-proteases
19. Fas ligand in human serum
20. Essential roles of the Fas ligand in the development of hepatitis
21. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver
22. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C
23. Serum levels of soluble Fas antigen in chronic hepatitis C patients
24. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
25. Functional modification of vascular endothelial cells by cytokines during septic shock
26. Plasma concentrations of type II phospholipase A2, cytokines and eicosanoids in patients with burns
27. Bound and soluble adhesion molecule and cytokine levels in patients with severe burns
28. Tumor necrosis factor-α and tumor necrosis factor receptor I, II levels in patients with severe burns
29. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
30. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL
31. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor
32. Delayed Fas-mediated hepatocyte apoptosis during liver regeneration in mice: Hepatoprotective role of TNF alpha